Drug: PREZISTA Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 15 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 113288034 | PREZISTA | Foetal exposure during pregnancy | ABBVIE | 0.00 | F | 0 | 20160707 | COUNTRY NOT SPECIFIED |
| 113817462 | PREZISTA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 0 | 20160804 | FR |
| 118485763 | PREZISTA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160712 | FR | |
| 121111444 | PREZISTA | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160718 | CH | |
| 125211391 | PREZISTA | Foetal exposure during pregnancy | JANSSEN | 7.00 MON | 0 | 20160701 | RO | |
| 125264971 | PREZISTA | Foetal exposure during pregnancy | RANBAXY | 39.00 DY | M | 3035 KG | 20160705 | US |
| 125471532 | PREZISTA | Foetal exposure during pregnancy | ABBVIE | 0.00 | M | 0 | 20160801 | COUNTRY NOT SPECIFIED |
| 125712491 | PREZISTA | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160719 | COUNTRY NOT SPECIFIED | |
| 125925042 | PREZISTA | Foetal exposure during pregnancy | JANSSEN | -0.22 YR | F | 3 KG | 20160810 | FR |
| 126018191 | PREZISTA | Foetal exposure during pregnancy | JANSSEN | 0.00 | 0 | 20160728 | US | |
| 126349991 | PREZISTA | Foetal exposure during pregnancy | JANSSEN | 0.00 | M | 0 | 20160809 | FR |
| 126424493 | PREZISTA | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160825 | COUNTRY NOT SPECIFIED | |
| 127549582 | PREZISTA | Foetal exposure during pregnancy | ABBVIE | 0.00 | M | 0 | 20160926 | COUNTRY NOT SPECIFIED |
| 127762491 | PREZISTA | Foetal exposure during pregnancy | ABBVIE | 0.00 DY | M | 0 | 20160923 | COUNTRY NOT SPECIFIED |
| 127818111 | PREZISTA | Foetal exposure during pregnancy | GILEAD | 0.00 YR | M | 3 KG | 20160926 | US |
Total Records: 15 Number of Pages: 1